Stratasys TrueDent Resins Earn CE Class IIa Marking, Expanding European Clinical Use

Stratasys' TrueDent resin portfolio has received CE marking as a Class IIa medical device in Europe, a regulatory step-up that the Minnesota- and Rehovot-based company says makes it the first high-esthetic, monolithic 3D-printed denture solution to achieve that certification on the continent. The upgrade expands approved clinical applications to include polychromatic, monolithic 3D-printed dentures, removable partial dentures, and crowns and bridges, moving well beyond the removable-denture-only scope permitted under its earlier Class I status.

TrueDent-D was introduced in Europe in early 2025 under a CE Class I designation for denture production. The jump to Class IIa under the European Medical Device Regulation required independent third-party evaluation and rigorous oversight, validating the portfolio's biocompatibility, manufacturing controls, traceability protocols, and clinical safety and performance for dental labs, clinics, and patients alike.

For labs and clinics already running the Stratasys J5 DentaJet printer, the practical impact on daily workflows is minimal. The transition to CE Class IIa requires no changes to print settings, formulation, workflow, or shelf life on that platform. Stratasys is providing a defined conversion kit to move existing users from TrueDent-D to the newly certified TrueDent resins while preserving established production processes and outcomes.

"Achieving CE Class IIa certification for TrueDent is an important milestone and supports the continued expansion of our dental business in Europe," said Chris Kabot, Vice President Dental, Stratasys. "By aligning TrueDent with the regulatory classification customers know and expect, we are providing additional clarity and confidence for clinicians and laboratories as they expand digital denture and temporary restoration workflows across the region."

The certification positions Stratasys more aggressively in a market the company pegs at more than $2 billion. Regulatory qualification has increasingly become the decisive competitive lever for European dental 3D printing, with multiple players racing to secure Class IIa status. Turkish manufacturer Dentafab, for example, secured CE Class IIa certification for its PowerResins Temp and Denture materials, with CEO Hakan Güzelgöz stating the accreditation would accelerate the spread of its products across European countries.

For Stratasys, the Class IIa elevation removes the ceiling that Class I imposed, unlocking the higher-value restorative segment where procurement decisions in dental labs and clinical settings hinge directly on device classification. With the J5 DentaJet workflow unchanged and a conversion path already defined, the path from Class I production to fully certified Class IIa clinical output is now a paperwork exercise rather than a retooling effort.